Pilot Trial of XFBD, a TCM, in Persons With COVID-19
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to document the safety of taking traditional Chinese medicine
(TCM) in patients with COVID-19 and to gain information to determine whether a study with TCM
can be conducted. The study will test a traditional Chinese medicine that has been made into
a granule formulation called Xuanfei Baidu Granules.